ICD-10-CM Code D02.21

Carcinoma in situ of right bronchus and lung

Version 2021 Billable Code Neoplasm CaInSitu

Valid for Submission

D02.21 is a billable code used to specify a medical diagnosis of carcinoma in situ of right bronchus and lung. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code D02.21 might also be used to specify conditions or terms like carcinoma in situ of bronchus and lung, carcinoma in situ of bronchus and lung, carcinoma in situ of bronchus and lung, carcinoma in situ of bronchus and lung, carcinoma in situ of bronchus of right lower lobe, carcinoma in situ of bronchus of right middle lobe, etc

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic bronchus middle lobe of lung or Neoplasm, neoplastic lung middle lobe .

ICD-10:D02.21
Short Description:Carcinoma in situ of right bronchus and lung
Long Description:Carcinoma in situ of right bronchus and lung

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Carcinoma in situ of bronchus and lung
  • Carcinoma in situ of bronchus and lung
  • Carcinoma in situ of bronchus and lung
  • Carcinoma in situ of bronchus and lung
  • Carcinoma in situ of bronchus of right lower lobe
  • Carcinoma in situ of bronchus of right middle lobe
  • Carcinoma in situ of bronchus of right upper lobe
  • Carcinoma in situ of lower lobe bronchus and lung
  • Carcinoma in situ of middle lobe bronchus and lung
  • Carcinoma in situ of right lower lobe of lung
  • Carcinoma in situ of right middle lobe of lung
  • Carcinoma in situ of right upper lobe of lung
  • Carcinoma in situ of upper lobe bronchus and lung
  • Neoplasm of bronchus of right lower lobe
  • Neoplasm of bronchus of right middle lobe
  • Neoplasm of bronchus of right upper lobe

Diagnostic Related Groups

The ICD-10 code D02.21 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2021.

  • 180 - RESPIRATORY NEOPLASMS WITH MCC
  • 181 - RESPIRATORY NEOPLASMS WITH CC
  • 182 - RESPIRATORY NEOPLASMS WITHOUT CC/MCC

Convert D02.21 to ICD-9

  • 231.2 - Ca in situ bronchus/lung (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of middle ear and respiratory system (D02)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Table of Neoplasms

The code D02.21 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »bronchus
    »middle lobe of lung
C34.2C78.0D02.21D14.31D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »middle lobe
C34.2C78.0D02.21D14.31D38.1D49.1

Information for Patients


Lung Cancer

Also called: Bronchogenic carcinoma

Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer. High levels of pollution, radiation and asbestos exposure may also increase risk.

Common symptoms of lung cancer include

  • A cough that doesn't go away and gets worse over time
  • Constant chest pain
  • Coughing up blood
  • Shortness of breath, wheezing, or hoarseness
  • Repeated problems with pneumonia or bronchitis
  • Swelling of the neck and face
  • Loss of appetite or weight loss
  • Fatigue

Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute

  • After chemotherapy - discharge (Medical Encyclopedia)
  • Coughing up blood (Medical Encyclopedia)
  • Lung cancer (Medical Encyclopedia)
  • Lung cancer - non-small cell (Medical Encyclopedia)
  • Lung cancer - small cell (Medical Encyclopedia)
  • Lung PET scan (Medical Encyclopedia)
  • Lung surgery (Medical Encyclopedia)
  • Metastatic cancer to the lung (Medical Encyclopedia)
  • Solitary pulmonary nodule (Medical Encyclopedia)

[Learn More]